ARVO Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eells, J.
Right arrow Articles by Carroll, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Eells, J.
Right arrow Articles by Carroll, J.
Invest Ophthalmol Vis Sci 2013;54: E-Abstract 1267.
© 2013 ARVO


1267

Photobiomodulation Preserves Mitochondrial Redox State and is Retinoprotective in a Rodent Model of Retinitis Pigmentosa

Janis Eells1, Sandeep Gopalakrishnan2, Mahsa Ranji4, Sepideh Maleki4, Betsy Abroe1, Heather Schmitt6, Adam Dubis5, Phyllis Summerfelt3 and Joseph Carroll3

1 Biomedical Sciences, Univ of Wisconsin - Milwaukee, Milwaukee, WI
2 Physiology, Medical College of Wisconsin, Milwaukee, WI
3 Ophthalmology, Medical College of Wisconsin, Milwaukee, WI
4 Electrical Engineering and Computer Science, University of Wisconsin-Milwaukee, Milwaukee, WI
5 Ophthalmology, Duke University, Durham, NC
6 Ophthalmology, University of Wisconsin, Madison, WI

Commercial Relationships: Janis Eells, QBMI Photomedicine (C); Sandeep Gopalakrishnan, None; Mahsa Ranji, None; Sepideh Maleki, None; Betsy Abroe, None; Heather Schmitt, None; Adam Dubis, None; Phyllis Summerfelt, None; Joseph Carroll, Imagine Eyes, Inc. (S)

Support: None

Abstract

Purpose:Photobiomodulaton (PBM) by light in the far-red to near-infrared (NIR) region of the spectrum has been demonstrated to attenuate the severity of neurodegenerative disease in experimental and clinical studies. The purpose of this study was to test the hypothesis that a brief course of 830 nm PBM would protect against the loss of retinal function and improve photoreceptor survival in a rodent model of retinitis pigmentosa, the P23H transgenic rat.

Methods:All studies were conducted in compliance with the ARVO Statement for the Use of Animals in Ophthalmic and Visual Research. P23H pups were treated once per day with 830 nm light (180 s; 25 mW/cm2; 4.5 J/cm2) using a light-emitting diode array (QBMI Photomedicine, Barneveld WI) from postnatal day (p) 10 to p25. Sham-treated rats were restrained for 180 seconds, but not exposed to NIR light. The status of the retina was determined at p30 by measuring photoreceptor function by electroretinography (ERG), retinal morphology by spectral domain optical coherence tomography (SD-OCT) and retinal metabolic state by NADH/FAD redox imaging.

Results:NIR treatment preserved retinal function, retinal morphology and retinal metabolic state in NIR-treated animals in comparison to the sham-treated group. Rod and cone-mediated ERG responses over a range of flash intensities (from 10 mcd.s/m2 to 25000 cd.s/m2) were 50% greater at each light intensity in NIR-treated rats compared to sham controls. SD-OCT studies showed that NIR treatment preserved the structural integrity of the retina. Mitochondrial redox imaging studies showed that NIR treatment (1.02 ± 0.2) protected the retina against the shift towards a more oxidized state as measured by the retinal redox ratio (NADH RR) in the sham treatment (0.80 ± 0.1).

Conclusions:Results from this study demonstrate the retinoprotective effects of 830nm PBM in a widely studied animal model of retinal degeneration and support the use of PBM as an innovative, non-invasive therapeutic approach for the treatment of retinal degenerative disease.

Keywords: 696 retinal degenerations: hereditary • 615 neuroprotection • 648 photoreceptors

© 2013, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH